InVitria
The advent of recombinant antibody production in mammalian cell lines has revolutionized modern medicine. Clinical success of these agents has challenged the underlying biological manufacturing systems to produce quantities sufficient to supply the ever-expanding commercial markets. A fundamental focus for commercialization efforts was the optimization of cell culture media components utilized in the biologic manufacturing process.
Watch Now
This webinar will demonstrate how the power of a single-cell multiomic approach can be harnessed to comprehensively characterize T cells, and precisely monitor changes in differentiation, activation, and exhaustion signatures during in vitro cell stimulation.
Watch Now
genengnews
For more than 15 years, the costs of DNA sequencing and synthesis have been improving faster than Moore’s Law. The impacts of the improvements made to DNA sequencing are well known: whereas the original Human Genome Project cost several billion dollars, a human genome can be sequenced today for about $1,000. With DNA synthesis now available at a cost of pennies per base pair, users no longer have to undertake traditional cloning, introducing new ways of engineering biological systems.
Watch Now
As gene-modified cell therapies advance to address new indications, the need for rapid development of robust manufacturing processes becomes increasingly important.
Watch Now